MedPath

DSA Intragraft in Lung Transplantation: Diagnostic and Prognostic Value in Antibody Mediated Rejection

Not Applicable
Recruiting
Conditions
Donor Specific Antibodies
Antibody Mediated Rejection
Lung Transplant Recipient
Registration Number
NCT03702257
Lead Sponsor
University Hospital, Strasbourg, France
Brief Summary

The diagnosis of AMR in lung transplant recipients is difficult and often comes too late, because of lack of standardized definition. The diagnosis is nowadays based on an expert multidisciplinary approach involving clinical, histopathological and immunological criteria.

Hypothesis: the presence of intragraft donor specific antibodies (gDSAs) could be used as a new diagnostic tool for AMR in lung transplant recipients Study Objectives: to evaluate, in lung transplant patients with circulating DSAs, the diagnostic value of gDSAs in AMR and to analyze its prognostic value on graft outcome.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Diagnosis of AMR2 years

Sensitivity and specificity of the presence of gDSA for the diagnosis of AMR in lung transplant recipients with circulating DSA, as established by an expert pathologist panel and in accordance with recent international recommendations

Secondary Outcome Measures
NameTimeMethod
Comparaison in gDSA+ vs gDSAs- patients2 years

Incidence of graft loss

Trial Locations

Locations (5)

Hôpital Marie Lannelongue

🇫🇷

Le Plessis Robinson, France

CHU Nord

🇫🇷

Marseille, France

Hôpital Bichat

🇫🇷

Paris, France

Les Hôpitaux Universitaires de Strasbourg

🇫🇷

Strasbourg, France

Hôpital Foch

🇫🇷

Suresnes, France

Hôpital Marie Lannelongue
🇫🇷Le Plessis Robinson, France
Jérôme LE PAVEC
Contact
+33 1 40 94 24 30
lepavec@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.